午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
After anhui, liaoning again asked this 204 drugs to open the factory price!
 
Author:中國銘鉉 企劃部  Release Time:2017-8-1 10:11:44  Number Browse:654
 
Medical network - August 1, who planning commission of liaoning province medical devices in release on the investigation to verify the relevant drug purchase notice supply and production of inventory, and so on and so forth, of 204 drug procurement supply and production inventory, and so on and so forth to investigate and verify. 
 
The notice was aimed at providing a supply guarantee for the shortage of drugs, with 204 of the drugs being used as clinical shortages. 
 
Notice the time involved in drugs and in liaoning province on July 27, anhui medicine published in platform on the investigation to verify the relevant drug purchase notice supply and production of inventory, and so on and so forth of the 204 drugs involved in. 
 
The release of this notice in liaoning province is only one day apart from anhui province, which seems to show that the medical policy of various provinces is not small, which is worthy of the attention of medical professionals. 
 
On the other hand, you can see that although the specific situation of the shortage of drugs under the influence of transportation and regional factors, but between different regions, and types of drugs are also quite common, in front of drug shortage, the provincial relevant functional departments to take active intervention measures to safeguard the balance between supply and demand of the drug. 
 
▍ notice details include: 
 
I. the basic situation of enterprises 
 
Fill in address, name, enterprise production enterprise, production, sales director, director, head of the name, office phone, mobile phone number, and is currently in production in 2016, sales of drug varieties, ex-factory price, the enterprise has the API approval number and whether in the past two years in production, and so on and so forth. 
 
Ii. The inventory situation of the shortage of drugs in the list of medicines 
 
Control list of medicines (annex 1), determine the specific dosage form of the shortage of medicines, and fill in the relevant information. 
 
Difficulties and Suggestions 
 
In this paper, the problems and difficulties in the production and operation of drugs in the list are summarized, and Suggestions and Suggestions are put forward in the questionnaire. 
 
The health and family planning commission of liaoning province 
 
July 28, 2017 
 
Previous article:The price monopoly of raw material medicine, two pharmaceutical companies were punished by the national development and reform commission
Next article:In 2017, a total of 90 pharmaceutical companies in guangzhou have entered the rectification list
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號